Skip to main content

Home/ science/ Group items tagged diagnostics

Rss Feed Group items tagged

Nits Mahajan

In Vitro Diagnostics (IVD) Quality Control Market Worth 1,065.3 Million USD By 2022 - 0 views

  •  
    The rising need of faster and error free laboratory results, improving laboratory efficiency, and technological advancements in multi-analyte third party IVD quality controls are the major factors that significantly impacted the development in In Vitro Diagnostics Quality Controls Market. Global IVD quality controls market is expected to reach USD 1,065.3 million by 2022, at a CAGR of 3.8% during the forecast period of 2017 to 2022.
Tonny Johnson

How to Identify Clinically Successful Biomarkers? - 0 views

The decisive goal of clinical biomarker discovery should be intended for developing high quality and low-cost disease detection/monitoring assays with high diagnostic accuracy. Innovative approache...

personalized biomarker personal diagnostics imaging biomarkers diagnostic tools molecular next generation sequencing clinical cancer clinically useful discovery viable successful validation of

started by Tonny Johnson on 01 Oct 12 no follow-up yet
Tonny Johnson

Metabolon vs. Stemina - Are Biomarker Patents can be Considered as "True Inventions"? - 0 views

This scientific blog critically analyzes the limitations and pitfalls in biomarker patent process. According to the argument made in this blog, most of the biomarkers patents may not have commercia...

personalized biomarker personal diagnostics imaging biomarkers diagnostic tools molecular next generation sequencing clinical cancer clinically useful discovery viable successful validation of

started by Tonny Johnson on 17 Oct 12 no follow-up yet
Barry mahfood

Nanomedicine: Drug Delivery & Diagnostics Get a Boost - 0 views

  •  
    Nanotech is the key to some new methods of precision drug-delivery and diagnostics. Two spinoff companies in Austalia have announced some new products under development promise "to provide better health outcomes with reduced costs to the community." The specific projects currently in the pipeline at Interstitial NS are nanostructured medicines for diabetes and asthma whose nanoscale manufacture makes possible otherwise impractical delivery methods.
Nits Mahajan

Take Advantage Of Clinical Genomics Market - Read This Research Report By World Researc... - 0 views

  •  
    Clinical Genomics Market By Test Type (Diagnostic, Genetic, Newborn Screening, Prenatal, Carrier Screening), Software, Method (Molecular, Chromosomal, Biochemical Tests), End User (Hospitals and Clinics) - Global Forecast to 2023
thinkahol *

Does that hurt? Objective way to measure pain being developed - 0 views

  •  
    ScienceDaily (Sep. 14, 2011) - Researchers from the Stanford University School of Medicine have taken a first step toward developing a diagnostic tool that could eliminate a major hurdle in pain medicine -- the dependency on self-reporting to measure the presence or absence of pain. The new tool would use patterns of brain activity to give an objective physiologic assessment of whether someone is in pain.
Erich Feldmeier

About - BioMed X - 0 views

  •  
    "The BioMed X Innovation Center is an exciting new collaboration model at the interface between academia and industry. At our center, distinguished early career scientists recruited from all over the world are working jointly on novel pre-clinical research projects in the fields of biomedicine, molecular biology, cell biology, diagnostics, bioinformatics, neuroscience and nanomaterials. These interdisciplinary project teams are conducting outstanding biomedical research in an open innovation lab facility on the campus of the University of Heidelberg"
Skeptical Debunker

Phones, paper 'chips' may fight disease - CNN.com - 0 views

  • George Whitesides has developed a prototype for paper "chip" technology that could be used in the developing world to cheaply diagnose deadly diseases such as HIV, malaria, tuberculosis, hepatitis and gastroenteritis. The first products will be available in about a year, he said. His efforts, which find their inspiration from the simple designs of comic books and computer chips, are surprisingly low-tech and cheap. Patients put a drop of blood on one side of the slip of paper, and on the other appears a colorful pattern in the shape of a tree, which tells medical professionals whether the person is infected with certain diseases. Water-repellent comic-book ink saturates several layers of paper, he said. The ink funnels a patient's blood into tree-like channels, where several layers of treated paper react with the blood to create diagnostic colors. It's not entirely unlike a home pregnancy test, Whitesides said, but the chips are much smaller and cheaper, and they test for multiple diseases at once. They also show how severely a person is infected rather than producing only a positive-negative reading.
  •  
    A chemistry professor at Harvard University is trying to shrink a medical laboratory onto a piece of paper that's the size of a fingerprint and costs about a penny.
veera90

Life Sciences Regulatory Affairs Services | Regulatory Consulting | ACL Digital Life Sc... - 0 views

  •  
    Developing a sound regulatory strategy, in-depth understanding of the country or region-specific regulatory requirements for specific product categories, along with accurate interpretations, implications, and applicability of such regulations, are instrumental in achieving a global outreach for medical products. Whether the product is a medical device, diagnostics, biologics, or a pharmaceutical drug, a careful consideration of the regulatory strategy early on is crucial for securing timely clearances or approvals.
1 - 10 of 10
Showing 20 items per page